Hanmi Science Co., Ltd.
KSE 008930.KS
Hanmi Science Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 20.34 M
Hanmi Science Co., Ltd. Free Cash Flow is USD 20.34 M for the year ending December 31, 2023, a 2,220.66% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Hanmi Science Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 876.35 K, a -90.88% change year over year.
-
Hanmi Science Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 9.60 M, a -11.83% change year over year.
-
Hanmi Science Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 10.89 M, a 14.28% change year over year.
-
Hanmi Science Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 9.53 M, a 600.02% change year over year.
Key data
| Date | Free Cash Flow | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Market news
Loading...
KSE: 008930.KS
| CEO | Mr. Jong-Hoon Lim |
| IPO Date | Sept. 29, 2005 |
| Location | South Korea |
| Headquarters | 14, Wiryeseong-daero |
| Employees | 402 |
| Sector | Health Care |
| Industries | |
Description
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email